Source: Pediatric Blood and Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology. Unidades: FORP, FMRP, FFCLRP
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TONE, L. et al. Analysis of BCR/ABLI and TRGV/BJ (T-cell receptor) hybrid gene in pediatric patients submitted to chemo-AND/OR radiotherapy: evaluation of late effects. Pediatric Blood and Cancer. Hoboken: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2005APA
Tone, L., Camparoto, M. L., Brassesco, M. S., D'Arce, L. P. G., Fachin, A. L., Lima, A. P., et al. (2005). Analysis of BCR/ABLI and TRGV/BJ (T-cell receptor) hybrid gene in pediatric patients submitted to chemo-AND/OR radiotherapy: evaluation of late effects. Pediatric Blood and Cancer. Hoboken: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo.NLM
Tone L, Camparoto ML, Brassesco MS, D'Arce LPG, Fachin AL, Lima AP, Cardoso RS, Passos GAS, Scrideli CA, Tone LG, Sakamoto-Hojo ET. Analysis of BCR/ABLI and TRGV/BJ (T-cell receptor) hybrid gene in pediatric patients submitted to chemo-AND/OR radiotherapy: evaluation of late effects. Pediatric Blood and Cancer. 2005 ; 45( 4): 435.[citado 2024 nov. 10 ]Vancouver
Tone L, Camparoto ML, Brassesco MS, D'Arce LPG, Fachin AL, Lima AP, Cardoso RS, Passos GAS, Scrideli CA, Tone LG, Sakamoto-Hojo ET. Analysis of BCR/ABLI and TRGV/BJ (T-cell receptor) hybrid gene in pediatric patients submitted to chemo-AND/OR radiotherapy: evaluation of late effects. Pediatric Blood and Cancer. 2005 ; 45( 4): 435.[citado 2024 nov. 10 ]
